论文部分内容阅读
目的:分析研究瑞舒伐他汀钙治疗老年冠心病合并高脂血症的治疗疗效。方法:选取2015年11月至2016年11月在我院进行治疗的老年冠心病合并高脂血症的患者60例作为观察对象,按照不同的治疗方法将其分成对照组和观察组,每组30例;对照组予以阿托伐他汀钙进行治疗,观察组予以瑞舒伐他汀钙进行治疗;经过2个月的治疗,对比分析两组患者的血脂水平以及治疗疗效。结果:观察组患者的血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-C)均低于对照组患者(P<0.05),观察组患者的高密度脂蛋白(HDL-C)高于对照组患者(P<0.05);观察组患者的治疗有效率明显高于对照组患者(P<0.05);以上内容组间差异显著,具有统计学意义。结论:采用瑞舒伐他汀钙治疗老年冠心病合并高脂血症,治疗效果确切,能显著改善患者的血脂水平,安全性高,值得临床借鉴。
Objective: To analyze the effect of rosuvastatin calcium in the treatment of senile coronary heart disease complicated with hyperlipidemia. Methods: Sixty elderly patients with coronary heart disease and hyperlipidemia who were treated in our hospital from November 2015 to November 2016 were selected as observation subjects and divided into control group and observation group according to different treatment methods. Each group 30 cases in the control group were treated with atorvastatin calcium, the observation group was treated with rosuvastatin calcium; after 2 months of treatment, comparative analysis of the two groups of patients with lipid levels and therapeutic effect. Results: The levels of total cholesterol (TC), triglyceride (TG) and low density lipoprotein (LDL-C) in the observation group were lower than those in the control group (P0.05) .High density lipoprotein HDL-C) was higher than that of the control group (P <0.05). The treatment effective rate in the observation group was significantly higher than that in the control group (P <0.05). The differences between the above groups were significant and statistically significant. Conclusion: The use of rosuvastatin calcium in elderly patients with coronary heart disease complicated with hyperlipidemia, the treatment effect is exact, can significantly improve the patient’s blood lipid levels, high safety, it is worth learning from.